UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042930
Receipt number R000048353
Scientific Title Association between fasting time in pregnant women and hypoglycemia in neonates: A prospective cohort study
Date of disclosure of the study information 2021/02/20
Last modified on 2024/03/31 21:46:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to investigate the association between fasting time in pregnant women and hypoglycemia in neonates: A prospective cohort study

Acronym

Fasting time and hypoglycemia in neonates study

Scientific Title

Association between fasting time in pregnant women and hypoglycemia in neonates: A prospective cohort study

Scientific Title:Acronym

A Study on Fasting Time and hypoglycemia in neonates

Region

Japan


Condition

Condition

Blood glucose levels in neonates

Classification by specialty

Obstetrics and Gynecology Pediatrics Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether hypoglycemia in neonates is more likely to occur when pregnant women fast for a longer time before delivery than a shorter time.

Basic objectives2

Others

Basic objectives -Others

Prognosis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of hypoglycemia in neonates

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Pregnant women delivering at the facility and neonates born by the women

Key exclusion criteria

1.Pregnant women with type 1 diabetes
2.Congenital disorders of carbohydrates, metabolism, and hormones in neonates
3.Died at birth

Target sample size

1100


Research contact person

Name of lead principal investigator

1st name Taku
Middle name
Last name Iwami

Organization

Kyoto University

Division name

Kyoto University Health Service

Zip code

6068501

Address

Yoshida-Honmachi, Sakyo-ku, Kyoto

TEL

075-753-2404

Email

iwami.taku.8w@kyoto-u.ac.jp


Public contact

Name of contact person

1st name Yuto
Middle name
Last name Makino

Organization

Graduate School of Medicine and Faculty of Medicine Kyoto University

Division name

Department of Preventive Service

Zip code

6068501

Address

Yoshida-Honmachi, Sakyo-ku, Kyoto

TEL

075-753-2404

Homepage URL


Email

makino.yuto.83n@st.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Health Service

Institute

Department

Personal name



Funding Source

Organization

Kyoto University Health Service

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate school and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

696

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 12 Month 16 Day

Date of IRB

2021 Year 06 Month 30 Day

Anticipated trial start date

2021 Year 10 Month 11 Day

Last follow-up date

2024 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The study design is a prospective cohort study.
Blood glucose will be measured immediately after birth in neonates as the primary outcome.
The enrollment period for the study subjects is from after the approval of the Ethics Committee to April 30, 2022. If the target sample size is reached during the study, enrollment will be suspended. We will also consider extending the enrollment period if the number of outcomes is low.
The observation period will be from the date of registration to the first blood glucose test after delivery. The observation period for those scheduled for outpatient visits up to 2 years of age after birth will be up to 2 years up to that point.


Management information

Registered date

2021 Year 01 Month 06 Day

Last modified on

2024 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048353


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name